Kappa opioid antagonist effects of the novel kappa antagonist 5′-guanidinonaltrindole (GNTI) in an assay of schedule-controlled behavior in rhesus monkeys

Psychopharmacology

Volumn 163, Issue 3-4, 2002, Pages 412-419

  Negus, Stevens S ^a   Mello, Nancy K ^a   Linsenmayer, David C ^a   Jones, R ^b   Portoghese, Philip S ^b  

^a MCLEAN HOSPITAL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

5 Guanidinonaltrindole; Kappa opioid receptor; Nor binaltorphimine; Rhesus monkey

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; 4 [ALPHA (4 ALLYL 2,5 DIMETHYL 1 PIPERAZINYL) 3 METHOXYBENZYL] N,N DIETHYLBENZAMIDE; 5' GUANIDINONALTRINDOLE; DELTA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR ANTAGONIST; MORPHINE; MU OPIATE RECEPTOR; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; NORBINALTORPHIMINE; OPIATE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; DRUG RESPONSE; DRUG SELECTIVITY; MALE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BLOCKING; REINFORCEMENT; RHESUS MONKEY; TIME;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ANALGESICS; ANALGESICS, NON-NARCOTIC; ANIMALS; BENZAMIDES; BENZENEACETAMIDES; CONDITIONING, OPERANT; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; FEMALE; MACACA MULATTA; MALE; MORPHINE; NALTREXONE; NARCOTIC ANTAGONISTS; NARCOTICS; PIPERAZINES; PYRROLIDINES; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, KAPPA; REINFORCEMENT SCHEDULE; TIME FACTORS;

EID: 0036390018     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-002-1038-x     Document Type: Article

References (29)

1. Bergman J, Warren PH (1989) Effects of kappa opioids on schedule-controlled behavior of squirrel monkeys. J Pharmacol Exp Ther 248:1102-1108
2. 2 analysis. J Pharmacol Exp Ther 243:591-597
3. Birch PJ, Hayes AG, Sheehan MJ, Tyers MB (1987) Norbinaltorphimine: antagonist profile at k opioid receptors. Eur J Pharmacol 144:405-408
4. Brandt MR, Furness MS, Rice KC, Fischer BD, Negus SS (2001) Studies of tolerance and dependence with the delta-opioid agonist SNC80 in rhesus monkeys responding under a schedule of food presentation. J Pharmacol Exp Ther 299:629-637
5. Broadbear JH, Negus SS, Butelman ER, Costa BR de, Woods JH (1994) Differential effects of systemically administered nor-binaltorphimine (nor-BNI) on k-opioid agonists in the mouse writhing assay. Psychopharmacology 115:311-319
6. Butelman ER, Negus SS, Ai Y, Costa BR de, Woods JH (1993) Kappa opioid antagonist effects of systemically administered nor-binaltorphimine (nor-BNI) in a thermal antinociception assay in rhesus monkeys. J Pharmacol Exp Ther 257:1269-1276
7. Butelman ER, Negus SS, Lewis JW, Woods JH (1996) Clocinnamox antagonism of opioid suppression of schedule-controlled responding in rhesus monkeys. Psychopharmacology 123:320-324
8. Dews PB (1956) Modification by drugs of performance on simple schedules of positive reinforcement. Ann NY Acad Sci 65:268-281
9. Downs DA, Woods JH (1976) Morphine, pentazocine and naloxone effects on responding under a multiple schedule of reinforcement in rhesus monkeys. J Pharmacol Exp Ther 196: 298-306
10. Emmerson PJ, Liu M-R, Woods JH, Medzihradsky F (1994) Binding affinity and selectivity of opioids at mu, delta and kappa receptors in monkey brain membranes. J Pharmacol Exp Ther 271:1630-1637
11. Endoh T, Matsuura H, Tanaka C, Nagase H (1992) Nor-binaltorphimine: a potent and selective k-opioid receptor antagonist with long-lasting activity in vivo. Arch Int Pharmacodyn 316:30-42
12. France CP, Morse WH (1989) Pharmacological characterization of supersensitivity to naltrexone in squirrel monkeys. J Pharmacol Exp Ther 250:928-936
13. Horan P, Taylor J, Yamamura HI, Porreca F (1992) Extremely long-lasting antagonistic actions of nor-binaltorphimine (nor-BNI) in the mouse tail-flick test. J Pharmacol Exp Ther 260:1237-1243
14. Jewett DC, Woods JH (1995) Nor-binaltorphimine: an ultra-long acting kappa-opioid antagonist in pigeons. Behav Pharmacol 6:815-820
15. Jewett DC, Grace MK, Jones RM, Billington CJ, Portoghese PS, Levine AS (2001) The kappa-opioid antagonist GNTI reduces U50,488-, DAMGO-, and deprivation-induced feeding, but not butorphanol- or neuropeptide Y-induced feeding, in rats. Brain Res 909:75-80
16. Jones DNC, Holtzman SG (1992) Long term k-opioid receptor blockade following nor-binaltorphimine. Eur J Pharmacol 215:345-348
17. Jones RM, Portoghese PS (2000) 5′-Guanidinonaltrindole, a highly selective and potent k-opioid receptor antagonist. Eur J Pharmacol 396:49-52
18. Jones RM, Hjorth SA, Schwarts TW, Portoghese PS (1998) Mutational evidence for a common k antagonist binding pocket in the wild-type k and mutant μ(K303E) opioid receptors. J Med Chem 41:4911-4914
19. Kelleher RT, Morse WH (1968) Determinants of the specificity of behavioral effects of drugs. Ergeb Physiol Biol Chem Exp Pharmakol 60:1-56
20. McMillan DE, Morse WH (1967) Some effects of morphine and morphine antagonists on schedule-controlled behavior. J Pharmacol Exp Ther 157:175-184
21. Negus SS, Burke TF, Medzihradsky F, Woods JH (1993) Effects of opioid agonists selective for mu, kappa and delta opioid receptors on schedule-controlled responding in rhesus monkeys: antagonism by quadazocine. J Pharmacol Exp Ther 267: 896-903
22. Negus SS, Butelman ER, Chang KJ, DeCosta BR, Winger G, Wood JH (1994) Behavioral effects of the systemically active delta opioid agonist BW373U86 in rhesus monkeys. J Pharmacol Exp Ther 270:1025-1034
23. Negus SS, Gatch MB, Mello NK, Zhang X, Rice K (1998) Behavioral effects of the delta-selective opioid agonist SNC80 and related compounds in rhesus monkeys. J Pharmacol Exp Ther 286:362-375
24. Portoghese PS (2001) From models to molecules: opioid receptor dimers, bivalent ligands, and selective opioid receptor probes. J Med Chem 44:2259-2269
25. Portoghese PS, Lipkowski AW, Takemori AE (1987) Binaltorphimine and norbinaltorphimine, potent and selective kappa opioid receptor antagonists. Life Sci 40:1287-1292
26. Reisine T, Pasternak G (1996) Opioid analgesics and antagonists. In: Hardman JG, Limbird LE (eds) The pharmacological basis of therapeutics, 9th edn. McGraw Hill, New York, pp 521-555
27. Stevens WC, Jones RM, Subramanian G, Metzger TG, Ferguson DM, Portoghese PS (2000) Potent and selective indolomorphinan antagonists of the kappa-opioid receptor. J Med Chem 43:2759-2769
28. Takemori AE, Ho BY, Naeseth JS, Portoghese PS (1988) Norbinaltorphimine (norBNI), a highly selective kappa-opioid receptor antagonist in analgesia and receptor binding assays. J Pharmacol Exp Ther 246:255-258
29. Thomas JB, Atkinson RN, Rothman RB, Fix SE, Mascarella SW, Vinson NA, Xu H, Dersch CM, Lu Y, Cantrell BE, Zimmerman DM, Carroll FI (2001) Identification of the first trans-(3R,4R)-dimethyl-4-(3-hydroxyphenyl)piperidine derivative to possess highly potent and selective opioid kappa receptor antagonist activity. J Med Chem 44:2687-2690